Chiral Cyclobutane-Containing Cell-Penetrating Peptides as Selective Vectors for Anti- Leishmania Drug Delivery Systems

Int J Mol Sci. 2020 Oct 12;21(20):7502. doi: 10.3390/ijms21207502.

Abstract

Two series of new hybrid γ/γ-peptides, γ-CC and γ-CT, formed by (1S,2R)-3-amino-2,2,dimethylcyclobutane-1-carboxylic acid joined in alternation to a Nα-functionalized cis- or trans-γ-amino-l-proline derivative, respectively, have been synthesized and evaluated as cell penetrating peptides (CPP) and as selective vectors for anti-Leishmania drug delivery systems (DDS). They lacked cytotoxicity on the tumoral human cell line HeLa with a moderate cell-uptake on these cells. In contrast, both γ-CC and γ-CT tetradecamers were microbicidal on the protozoan parasite Leishmania beyond 25 μM, with significant intracellular accumulation. They were conjugated to fluorescent doxorubicin (Dox) as a standard drug showing toxicity beyond 1 μM, while free Dox was not toxic. Intracellular accumulation was 2.5 higher than with Dox-TAT conjugate (TAT = transactivator of transcription, taken as a standard CPP). The conformational structure of the conjugates was approached both by circular dichroism spectroscopy and molecular dynamics simulations. Altogether, computational calculations predict that the drug-γ-peptide conjugates adopt conformations that bury the Dox moiety into a cavity of the folded peptide, while the positively charged guanidinium groups face the solvent. The favorable charge/hydrophobicity balance in these CPP improves the solubility of Dox in aqueous media, as well as translocation across cell membranes, making them promising candidates for DDS.

Keywords: anti-Leishmania drug delivery vectors; foldamers; selective cell-penetrating peptides; unnatural γ-amino acids.

MeSH terms

  • Antiprotozoal Agents / chemistry*
  • Antiprotozoal Agents / pharmacology*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Cell-Penetrating Peptides / chemistry*
  • Cyclobutanes / chemistry*
  • Drug Carriers / chemistry*
  • Drug Delivery Systems*
  • Drug Design
  • HeLa Cells
  • Humans
  • Models, Molecular
  • Molecular Structure
  • Parasitic Sensitivity Tests
  • Spectrum Analysis
  • Structure-Activity Relationship

Substances

  • Antiprotozoal Agents
  • Cell-Penetrating Peptides
  • Cyclobutanes
  • Drug Carriers